The U.S. Anti-Doping Agency (USADA) has announced a two year suspension for UFC’s Heavyweight Ruslan Magomedov (14-1) and Featherweight Zubaira Tukhugov (18-4) due to a failed drug test.
Both fighters have tested positive for ostarine in September 2016, some of its benefits include: increased lean mass gain, increased strength & endurance and joint healing abilities. UFC Strawweight Amanda Ribas (6-1), has recently tested positive for the substance in June 2017.
Both fighters have denied using ostarine and believe the positive test was due to a contaminated supplement. A fact that USADA wasn’t able to confirm.
USADA released the following statement:
The athletes presented testimony and submitted evidence in an attempt to support their supplement contamination claims and request for a reduced period of ineligibility. Nevertheless, after two days of testimony, USADA informed Magomedov and Tukhugov that it was still unwilling to consider a reduced sanction because it did not believe supplement contamination was a valid explanation for their positive tests.Thereafter, and before the conclusion of the hearing, USADA and the athletes reached an agreement to resolve the case, with Magomedov and Tukhugov each accepting a two-year period of ineligibility and agreeing to contribute a total of $10,000 toward the costs of the arbitration proceedings.
Magomedov was supposed to fight Stevan Struve (28-9) at UFC 204 but a staph infection forced him to pull out of the bout. Daniel Omielanczuk stepped in as a replacement and lost the fight via submission (brabo choke) in the second round. Ruslan’s last fight was in 2015 where he beat Shawn Jordan via unanimous decision at UFC 192.
Tukughov’s last fight dates to 2016 where he suffered his first UFC loss after Renato Carneiro (11-1) was able to get a split decision.